Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer

Abstract

The application of next-generation sequencing has led to the identification of three novel significantly mutated genes in CRC and a mutation signature that predicts survival outcomes for stratifying patients with CRC independent of TNM staging.